Search
for
Sort by
Research 121–150 of 232
- Eyelash trichomegaly complicating pembrolizumab for colorectal cancer
- Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis
- Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study
- Drug-Induced Hair Changes
- Alterazioni dei capelli da farmaci
- ODAC Chairs Reveal Challenges, High Drama in a Decade of Service
- Momentary fluke of cyclosporine in incidental repigmentation and hypertrichosis of hair
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Review of Drug Repositioning in Cancer Therapeutics
- 566 Staphylococcus epidermidis for the topical treatment of epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis
- 870 Y27632 promotes proliferation via EGFR signaling in a newly isolated and characterized human primary sebocyte cell line
- Folliculitis decalvans: why is there no established treatment?
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Back to the Roots—An Overview of the Chemical Composition and Bioactivity of Selected Root-Essential Oils
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- Significance of stress keratin expression in normal and diseased epithelia
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-standing Cases
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Maintaining Hair Inductivity in Human Dermal Papilla Cells: A Review of Effective Methods
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy